Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

61360 Press Releases
DateTitleCompany
08 Nov 11 Fuzheng Huayu Composition May Lead to Anti-Liver Fibrosis Treatment in U.S. Shanghai Sundise Traditional Chinese Medicine Co. Ltd.,
Published by
Business Wire
08 Nov 11 New Year's Resolutions: It Takes a Community and 21 Days to Change a Habit ERELEASES,
Published by
PR Newswire
08 Nov 11 Teeter Hang Ups Introduces New Fit-Series ERELEASES,
Published by
PR Newswire
08 Nov 11 Research and Markets: Biomet Profile (Biomaterials): Global Market Share Analysis by region, SWOT, Product Pipeline & Financials 2012 Research and Markets,
Published by
Business Wire
08 Nov 11 Research and Markets: Pharmaceutical Industry in China 2011 - The future of the Chinese Pharmaceutical Industry holds substantial growth potential Research and Markets,
Published by
Business Wire
08 Nov 11 BioCryst Pharmaceuticals Presents New BCX4208 Gout Data at the 2011 ACR/ARHP Annual Scientific Meeting BioCryst Pharmaceuticals,
Published by
Business Wire
08 Nov 11 Medidata Solutions Reports Third Quarter 2011 Results Medidata Solutions,
Published by
Business Wire
08 Nov 11 BIO-Europe® 2011 Accelerates Partnering in the Life Science Industry EBD Group,
Published by
Business Wire
08 Nov 11 Acorda Therapeutics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference Acorda Therapeutics Inc.,
Published by
Business Wire
08 Nov 11 Almac publishes Stage II colon cancer recurrence signature in the Journal of Clinical Oncology Almac
08 Nov 11 BioInvent holds Capital Markets Day in Stockholm BioInvent International AB,
Published by
Business Wire
08 Nov 11 Labcyte Secures NIH Funding for Advanced Biomarker Validation Program in Collaboration with Stanford University Labcyte Inc.,
Published by
Business Wire
08 Nov 11 Santarus to Present at November Investment Conferences Santarus Inc.,
Published by
Business Wire
08 Nov 11 AstraZeneca and Targacept Announce First Top-line Phase 3 Results for TC-5214 as an Adjunct Treatment in Patients with Major Depressive Disorder Targacept Inc.,
Published by
Business Wire
08 Nov 11 Targacept to Host Conference Call Today at 10:00 AM to Discuss Top-line Results from RENAISSANCE 3 Study of TC-5214 as an Adjunct to Antidepressant Treatment for Major Depressive Disorder Targacept Inc.,
Published by
Business Wire
08 Nov 11 ACCF/AHA/SCAI 2011 Guidelines for Percutaneous Coronary Intervention Incorporates Impella Support Abiomed,
Published by
Business Wire
08 Nov 11 Teva Announces Pricing of $5,000,000,000 of Senior Notes Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Nov 11 EpiCept Corporation Reports Third Quarter 2011 Operating and Financial Results EpiCept Corporation,
Published by
Business Wire
08 Nov 11 American Renal Associates Announces Third Quarter 2011 Conference Call Details American Renal Associates Holdings Inc.,
Published by
Business Wire
08 Nov 11 All-Oral Treatment Regimen of Bristol-Myers Squibb’s Investigational NS5A and NS3 Inhibitors Achieved 90% Sustained Virologic Response (SVR12) in Phase II Study Sentinel Cohort of Genotype 1b Null Responders Bristol-Myers Squibb Company,
Published by
Business Wire
08 Nov 11 SDIX to Report Third Quarter Results on November 14, 2011 SDIX,
Published by
Business Wire
08 Nov 11 SunLink Health Systems Reschedules Fiscal 2012 First Quarter Conference Call SunLink Health Systems Inc.,
Published by
Business Wire
08 Nov 11 INSERTING and REPLACING BRILINTA™ (ticagrelor) Receives Additional Class I Recommendation in New U.S. Guidelines from ACCF/AHA/SCAI for PCI AstraZeneca,
Published by
Business Wire
08 Nov 11 BRILINTA™ (ticagrelor) Receives Additional Class I Recommendation in New U.S. Guidelines from ACCF/AHA/SCAI for PCI AstraZeneca,
Published by
Business Wire
08 Nov 11 Accellent Inc. Announces Timing of Third Quarter 2011 Earnings Release and Conference Call Accellent Inc.,
Published by
Business Wire
08 Nov 11 IMS Health to Issue Third-Quarter 2011 Financial Results on November 11; Conference Call for Note Holders Scheduled for November 22 IMS Health,
Published by
Business Wire
08 Nov 11 pSivida Corp. Reports Results for the First Quarter Ended September 30, 2011 pSivida Corp.,
Published by
Business Wire
08 Nov 11 Ironwood Pharmaceuticals Provides Third Quarter 2011 Investor Update Ironwood Pharmaceuticals Inc.,
Published by
Business Wire
08 Nov 11 Singularity University Announces Dates for FutureMed 2012 Singularity University,
Published by
Business Wire
08 Nov 11 Curis to Present at the Lazard Capital Markets Healthcare Conference Curis Inc.,
Published by
Business Wire
Advertising